Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carroll

Showing results (1281-1290 of 1,434) with videos related to

Pageof 144
Sort By:
Nutrition and Cancer|November 7, 2022
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance StudyJeannette M Schenk, Menghan Liu, Marian L Neuhouser, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
Scientific Reports|March 4, 2021
Cell-free DNA concentration and fragment size as a biomarker for prostate cancerEmmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
The Journal of Urology|April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance StudyMichael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
Prostate Cancer and Prostatic Diseases|August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillanceAnnika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
JAMA|November 25, 2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trialJouke T Annema, Jan P van Meerbeeck, Robert C Rintoul, et al.
The Prostate|May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancerDean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMichael J Morris, Steven P Rowe, Michael A Gorin, et al.
Pageof 144

Showing results (1281-1290 of 1,434) with videos related to

Sort By:
Pageof 144
Nutrition and Cancer|November 7, 2022
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance StudyJeannette M Schenk, Menghan Liu, Marian L Neuhouser, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
Scientific Reports|March 4, 2021
Cell-free DNA concentration and fragment size as a biomarker for prostate cancerEmmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
The Journal of Urology|April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance StudyMichael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
Prostate Cancer and Prostatic Diseases|August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillanceAnnika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
JAMA|November 25, 2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trialJouke T Annema, Jan P van Meerbeeck, Robert C Rintoul, et al.
The Prostate|May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancerDean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMichael J Morris, Steven P Rowe, Michael A Gorin, et al.
Pageof 144